Skip to main content

Find Clinical Trials

Home
Conditions
Rosacea Subtype 1 (Erythematotelangiectatic)

Clinical trial condition

Rosacea Subtype 1 (Erythematotelangiectatic)

Explore clinical trials studying Rosacea Subtype 1 (Erythematotelangiectatic). Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Rosacea Subtype 1 (Erythematotelangiectatic) trial results

Not Yet Recruiting

Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy

NCT07521462

Conditions: Cardiovascular Diseases, Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic), +5 more
Locations: Not specified

View Trial Details

Completed

Brimonidine 0.33% for Rosacea-Related Facial Erythema

NCT07431476

Conditions: Behavior, Behavioral Symptoms, Cardiovascular Diseases, +7 more
Locations: Istanbul Training and Research Hospital, Department of Dermatology Istanbul, Turkey (Türkiye)

View Trial Details

Completed

Efficacy and Safety of Different Dose Regimens of Gabapentin for Treating Erythema/Flushing in Rosacea: A Randomized Controlled Trial

NCT06776445

Conditions: Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic), Skin Diseases, +1 more
Locations: First Affiliated Hospital of Chongqing Medical University Chongqing, China

View Trial Details

Completed

Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)

NCT01666509

Conditions: Rosacea Subtype 1 (Erythematotelangiectatic)
Locations: Study site 5 Bochum, Germany

Study site 2 Dülmen, Germany

Study Site 1 Münster, Germany

Study site 4 Paderborn, Germany

View Trial Details